|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INVERNESS MEDICAL TECHNOLOGY INC/DE, 10-Q, EX-10.1, 2000-08-11 |
Next: KELLEY PARTNERS 1994 DEVELOPMENT DRILLING PROGRAM, 10-Q, 2000-08-11 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENT FOR THE PERIOD ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRITY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<EXCHANGE-RATE> 1
<CASH> 5,351,437
<SECURITIES> 0
<RECEIVABLES> 27,245,140
<ALLOWANCES> 4,848,000
<INVENTORY> 14,778,302
<CURRENT-ASSETS> 44,219,271
<PP&E> 18,762,950
<DEPRECIATION> 7,764,854
<TOTAL-ASSETS> 116,894,965
<CURRENT-LIABILITIES> 63,563,221
<BONDS> 21,807,262
4,279,910
0
<COMMON> 25,626
<OTHER-SE> 26,757,653
<TOTAL-LIABILITY-AND-EQUITY> 116,894,965
<SALES> 78,148,154
<TOTAL-REVENUES> 78,304,286
<CGS> 45,434,864
<TOTAL-COSTS> 25,216,107
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 4,268,544
<INCOME-PRETAX> 5,249,604
<INCOME-TAX> 287,406
<INCOME-CONTINUING> 4,962,198
<DISCONTINUED> 0
<EXTRAORDINARY> (799,729)
<CHANGES> 0
<NET-INCOME> 4,162,469
<EPS-BASIC> 0.18
<EPS-DILUTED> 0.15
</TABLE>
|
|